N. Celik Et Al. , "Endoglin and obestatin levels, cardiometabolic risk factors and subclinical atherosclerosis in children aged 10-18 years.," Journal of pediatric endocrinology & metabolism : JPEM , vol.29, no.10, pp.1173-1180, 2016
Celik, N. Et Al. 2016. Endoglin and obestatin levels, cardiometabolic risk factors and subclinical atherosclerosis in children aged 10-18 years.. Journal of pediatric endocrinology & metabolism : JPEM , vol.29, no.10 , 1173-1180.
Celik, N., CİNAZ, P., BİDECİ, A., Derinkuyu, B. E., Emeksiz, H. C., DÖĞER, E., ... Damar, C.(2016). Endoglin and obestatin levels, cardiometabolic risk factors and subclinical atherosclerosis in children aged 10-18 years.. Journal of pediatric endocrinology & metabolism : JPEM , vol.29, no.10, 1173-1180.
Celik, Nurullah Et Al. "Endoglin and obestatin levels, cardiometabolic risk factors and subclinical atherosclerosis in children aged 10-18 years.," Journal of pediatric endocrinology & metabolism : JPEM , vol.29, no.10, 1173-1180, 2016
Celik, Nurullah Et Al. "Endoglin and obestatin levels, cardiometabolic risk factors and subclinical atherosclerosis in children aged 10-18 years.." Journal of pediatric endocrinology & metabolism : JPEM , vol.29, no.10, pp.1173-1180, 2016
Celik, N. Et Al. (2016) . "Endoglin and obestatin levels, cardiometabolic risk factors and subclinical atherosclerosis in children aged 10-18 years.." Journal of pediatric endocrinology & metabolism : JPEM , vol.29, no.10, pp.1173-1180.
@article{article, author={Nurullah Celik Et Al. }, title={Endoglin and obestatin levels, cardiometabolic risk factors and subclinical atherosclerosis in children aged 10-18 years.}, journal={Journal of pediatric endocrinology & metabolism : JPEM}, year=2016, pages={1173-1180} }